Wells Fargo Downgrades Bio-Techne to Equal-Weight, Raises Price Target to $73

Wells Fargo analyst Brandon Couillard downgrades Bio-Techne (NASDAQ:TECH) from Overweight to Equal-Weight and raises the price target from $62 to $73.